Related Experiment Video
Updated: Jun 10, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Attenuated p53 Expression and Lack of Effect of TGFalpha on Cell Replication in Enzyme Altered Foci
P Lennartsson1, U Stenius, J Högberg
1Department of Occupational Toxicology, Institute of Environmental Health, Karolinska Institutet, Box 210, 171 Stockholm, Sweden.
Abstract:
Enzyme altered foci (EAF) in rat liver are stress-related precarcinogenic lesions. Control of the cell cycle in EAF hepatocytes is altered, and in vitro data indicate that p53 protein does not accumulate in these cells in response to DNA-damaging agents. In this report we present immunohistological data indicating that this p53 response is also attenuated in EAF in situ. The p53 response was 11 times more frequent in non-EAF than in EAF hepatocytes. The results are compared with previously reported in vitro studies. We also demonstrate that isolated EAF hepatocytes do not respond to TGFalpha and that four different p53-inducing agents, namely DEN, taxol, doxorubicin and araC readily induce p53 in non-EAF, but not in EAF hepatocytes. Taxol induces a similar toxicity in both these cell types. It is suggested that the attenuated response to DNA-damaging agents cannot be explained solely by altered metabolism of xenobiotics. Additional factors, such as an adaptive alteration in the control of p53 expression in EAF hepatocytes, must be involved.
Insights
Enzyme altered foci (EAF) in rat liver show a reduced p53 protein response to DNA-damaging agents. This suggests adaptive changes in EAF hepatocytes beyond altered metabolism.
Area of Science:
- Hepatology
- Carcinogenesis
- Molecular Biology
Background:
- Enzyme altered foci (EAF) are precarcinogenic lesions in rat liver associated with stress.
- Previous in vitro studies suggested EAF hepatocytes do not accumulate p53 protein in response to DNA-damaging agents.
Purpose of the Study:
- To investigate the in situ p53 protein response in EAF hepatocytes.
- To compare the p53 response in EAF versus non-EAF hepatocytes.
- To explore factors contributing to the attenuated p53 response in EAF.
Main Methods:
- Immunohistochemistry to assess p53 protein accumulation in situ.
- Treatment of isolated hepatocytes with p53-inducing agents (DEN, taxol, doxorubicin, araC) and TGFalpha.
- Evaluation of cellular toxicity.
Main Results:
- The p53 response was significantly attenuated in EAF hepatocytes compared to non-EAF hepatocytes (11 times less frequent).
- Isolated EAF hepatocytes did not respond to TGFalpha.
- DEN, taxol, doxorubicin, and araC induced p53 in non-EAF but not in EAF hepatocytes, despite similar taxol-induced toxicity.
Conclusions:
- The attenuated p53 response in EAF hepatocytes is an in situ phenomenon.
- Factors beyond altered xenobiotic metabolism contribute to this response.
- Adaptive alterations in p53 expression control within EAF hepatocytes are likely involved.
More Related Videos
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Replicative Cell Senescence
Inhibition of Cdk Activity

